| Dr Vien Xuan Nguyen, MD | |
|
3269 Stockton Hill Rd., Kingman Regional Medical Center, Hospital Medicine, Kingman, AZ 86409 | |
| (928) 681-8577 | |
| (480) 383-6121 |
| Full Name | Dr Vien Xuan Nguyen |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 3269 Stockton Hill Rd., Kingman, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477654358 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 058111 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kingman Regional Medical Center | Kingman, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kingman Healthcare Inc | 6901791367 | 181 |
News Archive
A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.
For the Matthews family the foster care-adoption process has not only transformed the lives of some terrific kids in need but also the lives of the Matthews themselves.
In an international first, people with lung cancer will find out if a new combination of drugs can kick-start their bodies' ability to fight back against the disease. They'll be part of a clinical trial now enrolling participants at the Medical University of South Carolina.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 3 days ago
| Entity Name | Kingman Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265423917 PECOS PAC ID: 6901791367 Enrollment ID: O20040216001173 |
News Archive
A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.
For the Matthews family the foster care-adoption process has not only transformed the lives of some terrific kids in need but also the lives of the Matthews themselves.
In an international first, people with lung cancer will find out if a new combination of drugs can kick-start their bodies' ability to fight back against the disease. They'll be part of a clinical trial now enrolling participants at the Medical University of South Carolina.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 3 days ago
| Entity Name | Hospitalist Medicine Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639594351 PECOS PAC ID: 5193948867 Enrollment ID: O20140527001440 |
News Archive
A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.
For the Matthews family the foster care-adoption process has not only transformed the lives of some terrific kids in need but also the lives of the Matthews themselves.
In an international first, people with lung cancer will find out if a new combination of drugs can kick-start their bodies' ability to fight back against the disease. They'll be part of a clinical trial now enrolling participants at the Medical University of South Carolina.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vien Xuan Nguyen, MD 3269 Stockton Hill Rd., Kingman Regional Medical Center, Hospital Medicine, Kingman, AZ 86409 Ph: (928) 681-8577 | Dr Vien Xuan Nguyen, MD 3269 Stockton Hill Rd., Kingman Regional Medical Center, Hospital Medicine, Kingman, AZ 86409 Ph: (928) 681-8577 |
News Archive
A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.
For the Matthews family the foster care-adoption process has not only transformed the lives of some terrific kids in need but also the lives of the Matthews themselves.
In an international first, people with lung cancer will find out if a new combination of drugs can kick-start their bodies' ability to fight back against the disease. They'll be part of a clinical trial now enrolling participants at the Medical University of South Carolina.
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
› Verified 3 days ago
Dr. Jeremy Harris Kaplan, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1739 E Beverly Ave Ste 101, Kingman, AZ 86409 Phone: 928-681-8715 | |
Deborah K Luckie, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3269 Stockton Hill Rd, Hospitalist Dept., Kingman, AZ 86409 Phone: 928-681-8577 | |
Dr. Ordessia Charran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1739 E Beverly Ave Ste 203, Kingman, AZ 86409 Phone: 928-757-3133 Fax: 928-757-3136 | |
Dr. Tiffany E Russell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1510 N Stockton Hill Rd, Kingman, AZ 86401 Phone: 928-753-1177 | |
Narayanaswamy Deepak, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1753 Airway Ave, Suite A, Kingman, AZ 86409 Phone: 928-757-4359 | |
Dr. Harris Salim, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3636 Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-757-3680 Fax: 928-757-3614 | |
Dr. S Ismail Ah Bokhari Sr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1720 E Beverly Ave, Suite B, Kingman, AZ 86409 Phone: 928-757-1333 Fax: 928-757-2367 |